Provided by Tiger Fintech (Singapore) Pte. Ltd.

Enanta Pharmaceuticals

7.45
-0.0100-0.13%
Post-market: 7.450.00000.00%16:20 EDT
Volume:179.21K
Turnover:1.35M
Market Cap:159.27M
PE:-1.72
High:7.81
Open:7.42
Low:7.37
Close:7.46
52wk High:13.37
52wk Low:4.09
Shares:21.38M
Float Shares:14.25M
Volume Ratio:0.79
T/O Rate:1.26%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.3219
EPS(LYR):-5.4849
ROE:-80.64%
ROA:-17.29%
PB:2.01
PE(LYR):-1.36

Loading ...

Company Profile

Company Name:
Enanta Pharmaceuticals
Exchange:
NASDAQ
Establishment Date:
1995
Employees:
131
Office Location:
4 Kingsbury Avenue,Watertown,Massachusetts,United States
Zip Code:
02472
Fax:
617 607 0530
Introduction:
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and license agreement with Abbott Laboratories to identify, develop, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir for the treatment of chronic hepatitis C virus. Enanta Pharmaceuticals, Inc. was founded in 1995 and is headquartered in Watertown, Massachusetts.

Directors

Name
Position
Bruce L. A. Carter
Director and non-executive Chairman of the Board
Jay R. Luly
President, Director and Chief Executive Officer
Kathleen S. Capps
Executive Director, Accounting, Controller and Interim Principal Accounting Officer
Kristine Peterson
Director
Lesley Russell
Director
Mark G. Foletta
Director
Terry Vance
Director
Yujiro S. Hata
Director

Shareholders

Name
Position
Jay R. Luly
President, Director and Chief Executive Officer
Brendan Luu
Chief Business Officer
Harry R. Trout, III
Vice President, Finance and Interim Principal Financial Officer
Kathleen S. Capps
Executive Director, Accounting, Controller and Interim Principal Accounting Officer
Matthew P. Kowalsky
Chief Legal Officer and Corporate Secretary
Paul J. Mellett
Chief Financial and Administrative Officer
Scott T. Rottinghaus
Chief Medical Officer
Tara L. Kieffer
Chief Product Strategy Officer
Yat Sun Or
Chief Scientific Officer